Merit Medical Systems, Inc. (MMSI)
Full history for every metric is available with a Kvantra account
No price history available.
Key financial summary
Financials in USD| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM | 2026E | ||
|---|---|---|---|---|---|---|---|---|---|
| Total revenue | $m | 964 | 1,075 | 1,151 | 1,257 | 1,357 | 1,515 | 1,579 | 1,636 |
| Operating profit | $m | 184 | 201 | ||||||
| Net profit | $m | -10 | 48 | 75 | 94 | 120 | 128 | 146 | 261 |
| EPS reported | $ | 2.13 | 2.42 | ||||||
| Operating cashflow per share | $ | 5.03 | 4.75 | ||||||
| Capex per share | $ | 1.43 | 1.34 | ||||||
| FCF per share | $ | 3.59 | 3.41 | ||||||
| Free cash flow | $m | 213 | 204 | ||||||
| Net debt | $m | 373 | 240 | ||||||
| Book value equity | $m | 1,584 | 1,680 | ||||||
| Book value per share | $ | 26.20 | 27.99 | ||||||
| Number of shares | m | 60.46 | 60.01 | ||||||
| DPS (TTM paid) | $ | 0.00 | 0.00 |
Financial summary
Financials in USD| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM | 2026E | ||
|---|---|---|---|---|---|---|---|---|---|
| Value | |||||||||
| P/E TTM | x | 41.38 | 36.16 | ||||||
| P/B LTM | x | 3.29 | 3.10 | ||||||
| P/S LTM | x | 3.44 | 3.30 | ||||||
| P/FCF LTM | x | 24.53 | 25.62 | ||||||
| EV/EBITDA LTM | x | 17.06 | 15.64 | ||||||
| EV/Sales LTM | x | 3.74 | 3.67 | ||||||
| Earnings Yield LTM | % | +2.42% | +2.77% | ||||||
| FCF Yield | % | +4.08% | +3.90% | ||||||
| Quality | |||||||||
| ROE | % | +8.11% | +9.07% | ||||||
| ROIC | % | +5.64% | +5.78% | ||||||
| Operating margin | % | +12.17% | +12.75% | ||||||
| Gross margin | % | +48.65% | +49.52% | ||||||
| FCF/Sales | % | +14.03% | +12.89% | ||||||
| Growth and momentum | |||||||||
| EPS Growth YoY | % | +4.93% | +19.21% | ||||||
| Sales Growth YoY | % | +11.66% | +16.41% | ||||||
| Net Income Growth YoY | % | +6.76% | +20.94% | ||||||
| FCF Growth | % | +16.29% | +11.35% | ||||||
| Operating Profit Growth | % | +18.42% | +29.33% | ||||||
| Dividend and capital structure | |||||||||
| Dividend Yield | % | 0.00% | 0.00% | ||||||
| Dividend Growth | % | - | - | ||||||
| Payout Ratio | % | 0.00% | 0.00% | ||||||
| FCF/Debt | x | 0.24 | 0.25 | ||||||
| Net Debt/EBITDA | x | 1.35 | 1.03 | ||||||
| EBIT/Net interest | x | 6.97 | 6.34 | ||||||
| Net debt/market cap | % | +15.76% | +13.59% | ||||||
| Net debt/Equity | x | 0.24 | 0.14 | ||||||
| Gross debt/equity | x | 0.57 | 0.49 | ||||||
Price target estimates
Based on consensus from external analysts. Not Kvantra's opinion.
Ratings
Based on consensus from external analysts. Not Kvantra's opinion.
ESG
| Metric | 2024 | 2025 | 2026 |
|---|---|---|---|
| ESG-score | |||
| Environmental score | |||
| Social score | |||
| Governance score | |||
| Risk rating |
Company overview
Merit Medical Systems, Inc. (MMSI) is engaged in the design, development, manufacturing, and worldwide commercialization of disposable medical products. These devices are crucial for a broad spectrum of diagnostic, therapeutic, and interventional procedures, primarily within the fields of cardiology, radiology, oncology, critical care, and endoscopy. The company operates through two main divisions: Cardiovascular and Endoscopy. Its extensive product portfolio includes advanced solutions for diagnosing and treating conditions in peripheral vessels and organs, as well as a comprehensive suite of cardiac intervention products. The latter encompasses tools for vascular access, angiography, electrophysiology, cardiac rhythm management, fluid and hemodynamic monitoring, hemostasis, and various interventional therapies for heart-related ailments. Additionally, MMSI provides customized procedural solutions, offering critical care items, disinfection protection systems, specialized syringes, manifold kits, and tailored trays and packs. Their offerings further extend to coated tubes and wires, alongside sophisticated sensor components for microelectromechanical systems (MEMS). The company also features pulmonary products, such as laser-cut tracheobronchial stents with their accompanying over-the-wire and direct visualization delivery systems, and dilation balloons used for endoscopic stricture dilation. Gastroenterology products, as well as essential kits and accessories for endoscopy and bronchoscopy procedures, complete their diverse catalog. Merit Medical Systems sells its products to a wide client base, including hospitals and healthcare professionals (physicians, technicians, and nurses) working in alternative care settings. Distribution channels include a direct sales force, authorized distributors, original equipment manufacturer (OEM) partnerships, and custom procedure tray manufacturers, reaching customers throughout the United States and internationally. Founded in 1987, Merit Medical Systems, Inc. has its corporate headquarters situated in South Jordan, Utah.
Similar companies
For informational purposes only. Kvantra provides data and quantitative analysis, not investment advice. KvantraRank is a mechanical model output. Analyst price targets and ratings are sourced from third parties and are not Kvantra recommendations. Past performance does not guarantee future results; all investments carry risk.
Merit Medical Systems, Inc. (MMSI)
No price history available.
Consensus from external analysts. Not Kvantra's opinion.
Based on consensus from external analysts. Not Kvantra's opinion.
Merit Medical Systems, Inc. (MMSI) is engaged in the design, development, manufacturing, and worldwide commercialization of disposable medical products. These devices are crucial for a broad spectrum of diagnostic, therapeutic, and interventional procedures, primarily within the fields of cardiology, radiology, oncology, critical care, and endoscopy. The company operates through two main divisions: Cardiovascular and Endoscopy. Its extensive product portfolio includes advanced solutions for diagnosing and treating conditions in peripheral vessels and organs, as well as a comprehensive suite of cardiac intervention products. The latter encompasses tools for vascular access, angiography, electrophysiology, cardiac rhythm management, fluid and hemodynamic monitoring, hemostasis, and various interventional therapies for heart-related ailments. Additionally, MMSI provides customized procedural solutions, offering critical care items, disinfection protection systems, specialized syringes, manifold kits, and tailored trays and packs. Their offerings further extend to coated tubes and wires, alongside sophisticated sensor components for microelectromechanical systems (MEMS). The company also features pulmonary products, such as laser-cut tracheobronchial stents with their accompanying over-the-wire and direct visualization delivery systems, and dilation balloons used for endoscopic stricture dilation. Gastroenterology products, as well as essential kits and accessories for endoscopy and bronchoscopy procedures, complete their diverse catalog. Merit Medical Systems sells its products to a wide client base, including hospitals and healthcare professionals (physicians, technicians, and nurses) working in alternative care settings. Distribution channels include a direct sales force, authorized distributors, original equipment manufacturer (OEM) partnerships, and custom procedure tray manufacturers, reaching customers throughout the United States and internationally. Founded in 1987, Merit Medical Systems, Inc. has its corporate headquarters situated in South Jordan, Utah.
Unlock all fundamental data
Sign up for FreeUnlock all fundamental data
Sign up for Free